Grimes & Company’s Oaktree Specialty Lending OCSL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-6,876
Closed -$142K 313
2022
Q4
$142K Buy
+6,876
New +$138K 0.01% 274
2022
Q2
Sell
-7,785
Closed -$172K 291
2022
Q1
$172K Hold
7,785
0.01% 287
2021
Q4
$174K Hold
7,785
0.01% 288
2021
Q3
$165K Buy
7,785
+963
+14% +$20.3K 0.01% 290
2021
Q2
$137K Buy
6,822
+418
+7% +$8.37K 0.01% 292
2021
Q1
$119K Buy
+6,404
New +$115K 0.01% 271

Other funds holding OCSL

Grimes & Company's OCSL Position: Q1 2023 in Review

Grimes & Company sold out of Oaktree Specialty Lending (OCSL) in Q1 2023, closing a stake of 6,876 shares — an estimated $142K sold.

Grimes & Company first reported a position in OCSL in Q1 2021 and held it in 6 quarters. The position peaked at $174K in Q4 2021. 185 funds tracked by Wall St. Rank hold OCSL as of Q1 2023.

  • Grimes & Company reported no remaining Oaktree Specialty Lending position as of Q1 2023 after selling out during the quarter.
  • Grimes & Company sold 6,876 Oaktree Specialty Lending shares in Q1 2023, an estimated $142K.
  • Grimes & Company first reported a position in Oaktree Specialty Lending in Q1 2021 and held it in 6 quarters.
  • Grimes & Company's Oaktree Specialty Lending position peaked at $174K in Q4 2021.
  • 185 funds tracked by Wall St. Rank held Oaktree Specialty Lending as of Q1 2023.

Based on Grimes & Company's 13F filing for Q1 2023, filed 20 Apr 2023.